Designation: Research Scientist
Department: Urologic Oncology
University: National Institutes of Health
Country: United States
Q. Quentin Li is a distinguished research scientist at the National Institutes of Health, having previously served as an assistant professor at the Mary Babb Randolph Cancer Center, West Virginia University Robert C. Byrd Health Sciences Center. With a rich academic background, Dr. Li obtained his M.D. from China and practiced as a dermatologist at Sun Yat-Sen University School of Medicine. He furthered his education by earning an M.S. in Microbiology & Immunology and a Ph.D. in Pharmacology & Experimental Therapeutics from the University of Maryland School of Medicine.
Dr. Li's expertise extends to molecular and cell biology of cancer, honed during his postdoctoral training in the Medical Oncology Branch of the Center for Cancer Research at the National Cancer Institute. He is an esteemed member of the American Association for Cancer Research, contributing significantly to the field through his role as principal investigator on several grants funded by the National Institutes of Health and pharmaceutical companies.
Recognized for his outstanding contributions to the field of medicine and science, Dr. Li was elected to Who's Who in Medicine & Healthcare, Who's Who in Science & Engineering, Who's Who in America, and Who's Who in the World in 2002 and 2003. His dedication to advancing cancer research and his exemplary achievements make him a prominent figure in the scientific community.
Cellular metabolism, Cancer epigenetics, Cancer chemotherapy & epigenetic therapy, Molecular and cell biology of cancer, Photoimmunotherapy, Oncopharmacology, New antitumor drug research & development, Natural products as novel anticancer agents, Apoptosis & cell cycle control in cancer cells, DNA repair and platinum drug resistance in carcinomas, Identification of biomarkers & epigenetic markers for diagnosis & treatment of carcinomas, Epigenetic regulation of gene expression in T cells & tumor cells.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Send Information
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org
Copyright © 2020 Boffin Access Limited.
